Bain Capital’s acquisition of the lab equipment business comes less than one month after PerkinElmer said it would sell its name and analytical assets to private equity firm New Mountain Capital for $2.45 billion, the report said. Olympus will look to focus on its medical endoscopes and other therapeutic lines.
Evident sells microscopes, X-ray fluorescence analyzers and other optical instruments, and industrial endoscopes and related inspection equipment, the report said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
